Pooled surveillance testing for asymptomatic SARS-CoV-2 infections at a Veterinary Teaching Hospital College, University of Minnesota, December 2020-April 2021.

To evaluate the use of asymptomatic surveillance, we implemented a surveillance program for asymptomatic SARS-CoV-2 infection in a voluntary sample of individuals at the College of Veterinary Medicine at the University of Minnesota. Self-collected anterior nasal samples were tested using real time reverse transcription-polymerase chain reaction (RT-PCR), in a 5:1 pooled testing strategy, twice weekly for 18 weeks. Positive pools were deconvoluted into individual tests, revealing an observed prevalence of 0.07% (3/4,525). Pooled testing allowed for large scale testing with an estimated cost savings of 79.3% and modeling demonstrated this testing strategy prevented up to 2 workplace transmission events, averting up to 4 clinical cases. At the study endpoint, antibody testing revealed 80.7% of participants had detectable vaccine antibody levels while 9.6% of participants had detectable antibodies to natural infection.

Radio frequency glow discharge-induced acidification of fluoropolymers.

Fluoropolymer surfaces are unique in view of the fact that they are quite inert, have low surface energies, and possess high thermal stabilities. Attempts to modify fluoropolymer surfaces have met with difficulties in that it is difficult to control the modification to maintain bulk characteristics of the polymer. In a previously described method, the replacement of a small fraction of surface fluorine by acid groups through radio frequency glow discharge created a surface with unexpected reactivity allowing for attachment of proteins in their active states. The present study demonstrates that 1-ethyl-3-[3-dimethylaminopropyl] carbodiimide hydrochloride (EDC) reacts with the acid groups on fluoropolymer surfaces in a novel reaction not previously described. This reaction yields an excellent leaving group in which a primary amine on proteins can substitute to form a covalent bond between a protein and these surfaces. In an earlier study, we demonstrated that collagen IV could be deposited on a modified PTFE surface using EDC as a linker. Once collagen IV is attached to the surface, it assembles to form a functional stratum resembling collagen IV in native basement membrane. In this study, we show data suggesting that the fluorine to carbon ratio determines the acidity of the fluoropolymer surfaces and how well collagen IV attaches to and assembles on four different fluoropolymer surfaces.

Directed type IV collagen self-assembly on hydroxylated PTFE.

A method for the creation of a type IV collagen (CNIV) scaffold on polytetrafluoroethylene (PTFE) for endothelial cell attachment is described. This mimic for the basal lamina can be used in the seeding and retention of endothelial cells for blood contacting devices. The CNIV-PTFE production technique can be defined as three processes: (i) creation of a reactive superacidic/ionic PTFE surface with retained hydrophobic characteristics; (ii) activation of this surface via covalent attachment of N-(3-dimethylaminopropyl)-N'-ethylcarbodiimide (EDC); and (iii) conjugation of the EDC with human CNIV resulting in the covalent binding of protein to the PTFE surface. This article demonstrates exciting new results showing that a reaction of CNIV to this particular surface results in a unique matrix assembly of CNIV scaffolds similar to those found in the basal lamina. This assembly is concentration-dependant, occurring in a narrow window around 0.435 microM. Following the fabrication of the CNIV matrix assembly, porcine aortic endothelial cells (PAEC) were seeded onto this material. Results described in this article demonstrate that the PAEC subsequently aligned with the direction of shear, filled voids created by dead or detached cells, and divided during the 6 h of experimentation. Under static conditions, cells remained viable for 1 week of testing. This was not observed with PAEC attached to glass with adsorbed Vitrogen. In summary, this article describes a novel biotechnological breakthrough that enables the creation of stable endothelial cell monolayers useful for fabricating blood contacting devices.